| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A comprehensive analysis of BRCA2 gene: focus on mechanistic aspects of its functions, spectrum of deleterious mutations, and therapeutic strategies targeting BRCA2-deficient tumors
|
Shailani, Anjali
|
|
2018
|
35 |
3 |
p. 1-10
|
artikel
|
| 2 |
A phase I study of afatinib for patients aged 75 or older with advanced non-small cell lung cancer harboring EGFR mutations
|
Tanaka, Hisashi
|
|
2018
|
35 |
3 |
p. 1-6
|
artikel
|
| 3 |
Can anticancer chemotherapy promote the progression of brain metastases?
|
Amelot, Aymeric
|
|
2018
|
35 |
3 |
p. 1-8
|
artikel
|
| 4 |
Cell biology of glioblastoma multiforme: from basic science to diagnosis and treatment
|
Stoyanov, George S.
|
|
2018
|
35 |
3 |
p. 1-10
|
artikel
|
| 5 |
Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review
|
Guidi, Alessandro
|
|
|
35 |
3 |
|
artikel
|
| 6 |
Chemotherapy and immunotherapy for recurrent and metastatic head and neck cancer: a systematic review
|
Guidi, Alessandro
|
|
2018
|
35 |
3 |
p. 1-12
|
artikel
|
| 7 |
Combined pulmonary fibrosis and emphysema predicts recurrence following surgery in patients with stage I non-small cell lung cancer
|
Maeda, Ryo
|
|
2018
|
35 |
3 |
p. 1-10
|
artikel
|
| 8 |
Detailed pathologic analysis on the co-occurrence of non-seminomatous germ cell tumor subtypes in matched orchiectomy and retroperitoneal lymph node dissections
|
Spratt, Daniel E.
|
|
2018
|
35 |
3 |
p. 1-8
|
artikel
|
| 9 |
Efficacy and safety of nilotinib therapy in patients with newly diagnosed chronic myeloid leukemia in the chronic phase
|
Tokuhira, Michihide
|
|
2018
|
35 |
3 |
p. 1-8
|
artikel
|
| 10 |
Efficacy of doxorubicin after progression on carboplatin and paclitaxel in advanced or recurrent endometrial cancer: a retrospective analysis of patients treated at the Brazilian National Cancer Institute (INCA)
|
Moreira, Emeline
|
|
2018
|
35 |
3 |
p. 1-5
|
artikel
|
| 11 |
Expression of gremlin1 in gastric cancer and its clinical significance
|
Yamasaki, Yoichi
|
|
2018
|
35 |
3 |
p. 1-6
|
artikel
|
| 12 |
Expression of Hippo signaling pathway and Aurora kinase genes in chronic myeloid leukemia
|
Marsola, Ana Paula Zambuzi Cardoso
|
|
2018
|
35 |
3 |
p. 1-10
|
artikel
|
| 13 |
Factors involved in early lenvatinib dose reduction: a retrospective analysis
|
Suyama, Koichi
|
|
2018
|
35 |
3 |
p. 1-4
|
artikel
|
| 14 |
Genetic polymorphism of calcium-sensing receptor in women with breast cancer
|
Campos-Verdes, Larysse Maira
|
|
2018
|
35 |
3 |
p. 1-4
|
artikel
|
| 15 |
Hypofractionated postmastectomy radiotherapy with helical tomotherapy in patients with immediate breast reconstruction: dosimetric results and acute/intermediate toxicity evaluation
|
Orecchia, Roberto
|
|
2018
|
35 |
3 |
p. 1-11
|
artikel
|
| 16 |
Immunosuppressive monocytes (CD14+/HLA-DRlow/−) increase in childhood precursor B-cell acute lymphoblastic leukemia after induction chemotherapy
|
Lima, D. S.
|
|
2018
|
35 |
3 |
p. 1-5
|
artikel
|
| 17 |
Is the fatigue an adverse event of the second generation of hormonal therapy? Data from a literature-based meta-analysis
|
Roviello, Giandomenico
|
|
2018
|
35 |
3 |
p. 1-5
|
artikel
|
| 18 |
Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgens
|
Gomes, Inês Margarida
|
|
2018
|
35 |
3 |
p. 1-10
|
artikel
|
| 19 |
Long-term survival with modern therapeutic agents against metastatic melanoma—vemurafenib and ipilimumab in a daily life setting
|
Lang, B. M.
|
|
2018
|
35 |
3 |
p. 1-12
|
artikel
|
| 20 |
Modified biweekly cisplatin, docetaxel plus cetuximab (TPEx) as first-line treatment for patients with recurrent/metastatic head and neck cancer
|
Fuchs, Hannah
|
|
2018
|
35 |
3 |
p. 1-6
|
artikel
|
| 21 |
Prognostic value of epidermal growth factor receptor mutations and histologic subtypes with lung adenocarcinoma
|
Motono, Nozomu
|
|
2018
|
35 |
3 |
p. 1-6
|
artikel
|
| 22 |
The impact of anaemia, transfusion dependency, comorbidities and polypharmacy in elderly patients with low-risk myelodysplastic syndromes
|
Castelli, Roberto
|
|
2018
|
35 |
3 |
p. 1-5
|
artikel
|
| 23 |
The role of tumor-infiltrating lymphocytes (TILs) as a predictive biomarker of response to anti-PD1 therapy in patients with metastatic non-small cell lung cancer or metastatic melanoma
|
Uryvaev, Anton
|
|
2018
|
35 |
3 |
p. 1-9
|
artikel
|
| 24 |
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma
|
Improta, Giuseppina
|
|
2018
|
35 |
3 |
p. 1-6
|
artikel
|
Tijdschrift beschrijving